Predicting Clinical Outcomes of Critically Ill Patients

• Sponsor: National Taiwan University Hospital (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT04541849
• Collaborator: (none)
• Enrollment: 20,000
• Location: 1
• Anticipated Duration (Months): 41.7
• Patients Per Site Per Month: 480.1

Study Details

Study Description

Brief Summary

Australian and New Zealand Intensive Care Society (ANZICS) has built an Center of Outcome and Resource Evaluation (CORE) adult patients database (APD) of adult critically ill patients. ANZICS CORE APD has built an international collaboration of ICU database. National Taiwan University Hospital has joined this international collaboration and built the data according to the APD data dictionary with same value domain attributes and data element attributes. We retrospectively collected the data of patients discharged from the March 1, 2019 to March 20, 2020. This study aims to use the data to predict the clinical outcomes of these patients using statistical methods and machine learning.

Condition or Disease	Intervention/Treatment	Phase
Critical Illness	Other: Critical Care

Study Design

• Study Type: Observational
• Anticipated Enrollment: 20000 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: Predicting Clinical Outcomes of Critically Ill Patients in Intensive Care Units With De-identification Database
• Actual Study Start Date: Sep 10, 2020
• Anticipated Primary Completion Date: Dec 1, 2023
• Anticipated Study Completion Date: Mar 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
Critically ill patients	Other: Critical Care; Critical care in the intensive care units

Outcome Measures

Primary Outcome Measures

1. 30-day mortality [30 days]

   mortality status at 30 days after admission to intensive care unit

Secondary Outcome Measures

1. length of stay in intensive care unit [Time of discharge from intensive care unit, a median of 2-7 days]

   number of days in intensive care unite

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Critically ill patients admitted to intensive care units

Exclusion Criteria:

• patients aged less than 20 years

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	National Taiwan University Hospital	Taipei		Taiwan	100

Sponsors and Collaborators

• National Taiwan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: National Taiwan University Hospital
• ClinicalTrials.gov Identifier: NCT04541849
• Other Study ID Numbers: 202004016RINB
• First Posted: Sep 9, 2020
• Last Update Posted: Jul 6, 2022
• Last Verified: Jul 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Critical Illness

Study Results

No Results Posted as of Jul 6, 2022